|
Braveheart
|
9
|
Resverlogix Corp.
|
Sep 21, 2015 02:30PM
|
|
Can't be long now..
|
4
|
Resverlogix Corp.
|
Apr 27, 2020 02:32AM
|
|
Citigroup note on Epigenetics - a big initiation note published on 22 October
|
9
|
Resverlogix Corp.
|
Oct 26, 2015 08:59AM
|
|
Cleveland Clinic's Nissen says CETP inhibition unlikely to work
|
5
|
Resverlogix Corp.
|
Oct 12, 2015 10:13AM
|
|
Cowen presentation significance
|
8
|
Resverlogix Corp.
|
Mar 14, 2017 03:27AM
|
|
Dilution
|
6
|
Resverlogix Corp.
|
Jun 11, 2020 07:32AM
|
|
Eerily quiet....
|
3
|
Resverlogix Corp.
|
Feb 04, 2016 03:38PM
|
|
Expectations
|
12
|
Resverlogix Corp.
|
Sep 17, 2019 02:41PM
|
|
Explanation of difference between Endcrinology and CVD
|
3
|
Resverlogix Corp.
|
Oct 05, 2015 06:43AM
|
|
Friday fun - a trip down memory lane
|
3
|
Resverlogix Corp.
|
Mar 17, 2017 07:54AM
|
|
I am very excited
|
5
|
Resverlogix Corp.
|
Sep 24, 2015 09:10AM
|
|
Inflammation revisited
|
4
|
Resverlogix Corp.
|
May 12, 2020 04:13AM
|
|
Lilly to Discontinue Development of Evacetrapib
|
2
|
Resverlogix Corp.
|
Oct 12, 2015 08:54AM
|
|
Pointing in the right direction & bogus Lilly
|
20
|
Resverlogix Corp.
|
Jun 21, 2018 08:46AM
|
|
Positives & negatives
|
16
|
Resverlogix Corp.
|
Sep 15, 2015 09:15AM
|
|
Question on EMA vs FDA
|
10
|
Resverlogix Corp.
|
Sep 30, 2015 09:32AM
|
|
Re: ...is anybody out there at the AGM...?
|
3
|
Resverlogix Corp.
|
Oct 01, 2015 12:03PM
|
|
Re: A few thoughts on Soliris(Eculizumab) vs. RVX-208 for Compliment-related disease
|
9
|
Resverlogix Corp.
|
Sep 27, 2015 11:11AM
|
|
Re: A new mathematical formula for RVX
|
10
|
Resverlogix Corp.
|
Nov 06, 2015 12:25PM
|
|
Re: BearDown, Ledenfrog, Tundup and all other experts.....
|
10
|
Resverlogix Corp.
|
Oct 20, 2015 04:34AM
|
